Buscar en
Medicina Clínica Práctica
Toda la web
Inicio Medicina Clínica Práctica Differences in serum magnesium levels, folic acid, and infant outcomes in severe...
Información de la revista
Vol. 4. Núm. S1.
Technology Enhanced Medical Education International Conference (THEME 2019)
(Abril 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1165
Vol. 4. Núm. S1.
Technology Enhanced Medical Education International Conference (THEME 2019)
(Abril 2021)
Original article
Open Access
Differences in serum magnesium levels, folic acid, and infant outcomes in severe preeclampsia: A literature review
Visitas
1165
Deviserlina Babysa, Irfan Idrisb,
Autor para correspondencia
, Prihantonoc
a Department of Midwifery, Graduate School, Hasanuddin University, Indonesia
b Department of Pathology Anatomy, Faculty of Medicine, Hasanuddin University, Indonesia
c Department of Surgery, Faculty of Medicine, Hasanuddin University, Indonesia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Characteristics, instruments and selected study results.
Suplemento especial
Este artículo forma parte de:
Vol. 4. Núm S1

Technology Enhanced Medical Education International Conference (THEME 2019)

Más datos
Abstract
Objective

The purpose of this systematic review is to review studies on serum magnesium, folic acid levels in severe preeclampsia and see the impact of a mother with preeclampsia on her baby. Several studies have shown magnesium deficiency and folic acid to be a factor causing preeclampsia which also affects infant outcomes.

Method

The method used is an electronic database that has been published through the PubMed and Science Direct online libraries. Keywords used for article searches are based on study questions.

Results

From 4 articles as a whole discussion preeclampsia. The most common risk factor for preeclampsia is obesity followed by chronic hypertension and diabetes. The incidence of prematurity is also higher in preeclampsia patients. Mothers with preeclampsia have a worse prognosis for mothers and babies compared to normal pregnant women.

Conclusion

Preeclampsia still a public health problem because of its high incidence rate. Various countries have conducted research related to magnesium and folic acid associated with preeclampsia, this can be a material for consideration and early detection of the incidence of preeclampsia so that prevention and treatment of preeclampsia can be done earlier.

Keywords:
Severe preeclampsia
Magnesium
Folic acid
Infant outcomes
Texto completo
Introduction

Severe preeclampsia is a complication that occurs in pregnancy. Severe PE is characterized by hypertension where systolic blood pressure ≥160mmHg and/or diastolic blood pressure 110mmHg with proteinuria ≥300mg/day.1 If not handled properly, severe preeclampsia can develop into serious complications that can endanger the mother and fetus. Complications that can occur in the mother are HELLP syndrome, eclampsia, pulmonary edema, Disseminated intravascular coagulation (DIC), kidney disorders, abruption of the placenta, and can even result in maternal death. In the fetal complications that occur are low birth weight (LBW), premature birth, asphyxia, even perinatal death. Whereas in neonatal can experience neonatal respiratory disorders namely neonatal respiratory distress syndrome (NRDS), pneumonia, and low APGAR scores.2–4 The number of cases of preeclampsia in Indonesia reaches 128,273 or around 5.3% every year.5

Preeclampsia is very closely related to low levels of certain micronutrients. Some micronutrients that are important during pregnancy are folic acid and magnesium. Folic acid plays a role in reducing plasma homocysteine concentrations in pregnant women, homocysteine plays a role in maternal endothelial dysfunction by reducing nitric oxidation and oxidative stress. High homocysteine levels can damage blood vessels and also cause blood vessel blockage. Magnesium plays an important role in neurochemical transmission and peripheral vasodilation. High and low levels of magnesium in the body have an impact on heart stimulation and vascular tone, contractility, and reactivity. Low magnesium levels are associated with metabolic syndrome, type 2 diabetes, hypertension, and cause a decrease in blood flow to the brain and cerebral vasospasm.6–8

Various studies on serum magnesium and folic acid levels associated with preeclampsia and the link between preeclampsia mothers and infant outcomes have been carried out in various countries including Indonesia. This is an effort in handling and prevention as early as possible. Therefore, this literature review aims to look at differences in serum levels of magnesium, folic acid in severe preeclampsia and see the effects of preeclampsia on their babies.

Method

Keywords for article searches are identified based on research questions. The keywords consist of severe preeclampsia; magnesium; folic acid; baby's output. The PubMed and ScienceDirect Library is sought for relevant studies to explore serum levels of magnesium, folic acid, and infant outcomes in mothers with severe preeclampsia.

Results

Following the article inclusion criteria identified in the search were 47 articles. Then the particles are filtered out in the last ten years and the complete articles out of 10. Then filter out duplicate articles and articles that are relevant to the research objective of 4 articles.

Four articles reviewed were carried out in various countries including France, Iran, Canada, and Indonesia. Of the 4 articles selected, each article discusses the relationship between preeclampsia and fetal output, folic acid, and magnesium as well as risk factors for preeclampsia. Characteristics of selected studies are presented in Table 1. Two articles discuss the administration of folic acid and magnesium in preeclampsia mothers where it was found that preeclampsia mothers had lower levels of folic acid and magnesium than those in normal pregnant women.6,9–11

Table 1.

Characteristics, instruments and selected study results.

Author  Purpose  Population  Instrument  Study design  Result 
Benfateh et al.(2018)  To study the epidemiology of preeclampsia and identify risk factors and poor maternal and fetal prognosis factors  Mothers with preeclampsia with or without edema and/or patients with one or more complications  Medical record  Retrospective cohort  Risk factors that are often found are obesity, chronic hypertension, diabetes, abortion, age <24 years and >34 years, and perinatal death. Better prenatal care and early diagnosis can reduce the incidence of preeclampsia. 
Gumay et al.(2015)  Analyzing the relationship of severe preeclampsia with fetal outcomes  Patients who deliver with severe preeclampsia and their babies who have complete medical record data on fetal outcomes.  Medical record  Cross-sectional  There is a significant relationship between severe preeclampsia with SGA (small for gestational age), moderate to severe asphyxia and prematurity. 
Tavana and Hosseinmirzaei(2013)  To measure magnesium levels in preeclampsia and control groups since early pregnancy  Pregnant women with 18–22 weeks gestation  Colorimetry and use of Xylidl Blue  Cross-sectional  Magnesium levels in women with preeclampsia are lower than normal pregnant women. Examination of magnesium levels should be considered a predictive factor for preeclampsia during the first evaluation of pregnancy 
Wen et al.(2016)  Assess the effect of folic acid supplementation on pregnancy on the risk of preeclampsia.  Pregnant women with less than 20 weeks’ gestation    Prospective cohort  Supplementation of folic acid in pregnancy can reduce the risk of preeclampsia in pregnant women, especially in women who have a high risk of developing preeclampsia. 

Two articles discuss the effects of preeclampsia on the mother and fetus and risk factors for preeclampsia. The impact of preeclampsia that can occur in the mother is HELLP syndrome, eclampsia, pulmonary edema, disseminated intravascular coagulation (DIC), kidney disorders, abruption of the placenta, and can even result in maternal death.12 Mothers with preeclampsia can increase the risk of cardiovascular disease, including chronic hypertension, stroke, coronary artery disease, diabetes and kidney disease later in life.13 Severe preeclampsia can also have an impact on perinatal outcomes. Perinatal outcomes that often occur are LBW, IUGR, asphyxia, fetal distress, premature birth, even death.12,14

Discussion

From 4 articles as a whole discussion preeclampsia. Benfateh et al. explained the risk factors most often found in preeclampsia are obesity followed by chronic hypertension and diabetes. Patients with preeclampsia under the age of 24 are more at risk of eclampsia, while patients aged >34 years are more at risk for acute kidney failure, acute pulmonary edema. The incidence of prematurity in this article is also higher in preeclampsia patients. Mothers who have preeclampsia have a poor maternal and infant prognosis compared to normal pregnant women.15 Gumay et al. explained that women with severe preeclampsia had a 6.92 times SGA chance, severe asphyxia 7.2 times, mild–moderate asphyxia 2.48 times, and 3.3 times prematurity than normal pregnant women.16 Preeclampsia is very closely related to low levels of certain micronutrients. Some micronutrients that are important during pregnancy are folic acid and magnesium. Tavana et al. explained magnesium levels in preeclampsia mothers were lower even earlier in pregnancy than in the control group.9 Low serum magnesium levels can result in increased calcium associated with increased vascular contraction thereby increasing vascular tone. Increased vascular tone thickens the walls of blood vessels causing an increase in blood pressure.17 Besides magnesium, folic acid also plays a very important role during the pregnancy period. Wen et al. explained the lower incidence of preeclampsia in the group given folic acid supplementation than the group without folic acid supplementation.6 Giving folic acid supplementation during pregnancy planning and pregnancy is not only beneficial for fetal growth and development but is also useful for the prevention of preeclampsia especially in women who have a high risk of preeclampsia.

Conclusion

At present preeclampsia is still a public health problem due to its high incidence rate. This is one of the main causes of maternal and fetal morbidity and mortality. Various countries have conducted research related to magnesium and folic acid associated with preeclampsia, this can be a material for consideration and early detection of the incidence of preeclampsia so that the prevention and treatment of preeclampsia can be done earlier.

Conflict of interest

The authors declare no conflict of interest.

References
[1]
A. Hoshino, S. Obata, A. Tochio, K. Seki, E. Miyagi, S. Aoki.
Efficacy of expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension before 34 weeks gestation.
Pregnancy Hypertens, 15 (2019), pp. 177-180
[2]
(2019),
[3]
R. Aouache, L. Biquard, D. Vaiman, F. Miralles.
Oxidative stress in preeclampsia and placental diseases.
[4]
Z. Rakotomalala, D.M.A. Randriambololona, H.M. Andriampanarivo, H.M. Andriampanarivo, B. Rakotozanany, B. Rakotozanany, et al.
Facteurs de mauvais pronostic en cas de pré-éclampsie à Madagascar.
Med Sante Trop, 26 (2016), pp. 78-82
[5]
POGI PNPK Diagnosis dan Tatalaksana Preeklampsia.
(2016),
[6]
S.W. Wen, Y. Guo, M. Rodger, R.R. White, Q. Yang, G.N. Smith.
(2016),
[7]
H. Geiger, C. Wanner.
(2012),
[8]
S. Mittal, M. Shaikh, R. Thakur, D. Jain.
Comparison of serum calcium and magnesium levels between preeclamptic and normotensive healthy pregnant women.
Int J Reprod Contracept Obstet Gynecol, 3 (2014), pp. 959
[9]
Z. Tavana, S. Hosseinmirzaei.
(2013),
[10]
I. Malahayati.
(2016),
[11]
H. Devita, V.Y.A. Amran.
Hubungan Kadar Magnesium Dengan Kejadian Preeklamasi Pada Ibu Hamil Trimester Iii Di Rsup Dr. M. Djamil Padang Tahun 2015.
J Kesehat Masy Andalas, 10 (2017), pp. 136
[12]
J.Y. Suriya, A. Keepanasseril, K. Manikandan, D.K. Maurya, P. Veena, S. Soundara Raghavan.
Maternal ascites an independent prognostic factor in severe preeclampsia: a matched cohort study.
Arch Gynecol Obstet, 296 (2017), pp. 63-68
[13]
Nature Publishing Group, (2014),
[14]
L. Ghulmiyyah, B. Sibai.
Maternal mortality from preeclampsia/eclampsia.
[15]
M. Benfateh, S. Cissoko, H. Boufettal, J.J. Feige, N. Samouh, T. Aboussaouira, et al.
Risk factors and poor prognostic factors of preeclampsia in Ibn Rochd University Hospital of Casablanca: about 401 preeclamptic cases.
[16]
D.O. Gumay, H. Wijayanegara.
Zulmansyah – Hubungan Preeklamsi Berat dengan Hasil Luaran Janin (Fetal Outcome) di RSUD Al-Ihsan Kabupaten Bandung.
Glob Med Heal Commun, 53 (2015),
[17]
L. Spatling, H.G. Classen, K. Kisters, U. Liebscher, R. Rylander, W. Vierling, et al.
Supplementation of magnesium in pregnancy.
J Pregnancy Child Heal, 04 (2017),

Peer-review under responsibility of the scientific committee of the Technology Enhanced Medical Education International Conference (THEME 2019). Full-text and the content of it is under responsibility of authors of the article.

Copyright © 2021. The Authors
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos